Filing Details
- Accession Number:
- 0000905148-23-001527
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-24 17:37:11
- Reporting Period:
- 2023-11-21
- Accepted Time:
- 2023-11-24 17:37:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1865494 | Io Biotech Inc. | IOBT | Pharmaceutical Preparations (2834) | 870909276 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1865633 | Brian Burkavage | C/O Io Biotech, Inc. Ole Maaloes Vej 3 Copenhagen G7 2200 | Chief Accounting Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-21 | 5,000 | $0.99 | 6,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-11-22 | 5,000 | $1.04 | 11,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The transaction was executed in multiple trades in prices ranging from $1.03 to $1.04, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
